𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of in vitro and in vivo biotransformation in patients with liver disease of differing severity

✍ Scribed by H. Kraul; J. Truckenbrodt; A. Huster; R. Töpfer; A. Hoffmann

Publisher
Springer
Year
1991
Tongue
English
Weight
616 KB
Volume
41
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of two different biliary agen
Comparison of two different biliary agents in healthy subjects and in patients with liver disease
✍ R. Dudczak; K. Kletter; P. Angelberger; H. Frischauf 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 266 KB

The kinetics of the iminodiacetic acids, dimethyl and diethyl IDA were studied in patients without and with liver disease. Diethyl IDA seems to be superior to dimethyl IDA in its diagnostic usefulness. It shows lower urinary excretion and a faster liver uptake, leading to more pronounced differences

Cimetidine Kinetics and Dynamics in Pati
Cimetidine Kinetics and Dynamics in Patients with Severe Liver Disease
✍ Jean-Pierre Villeneuve; Hélène Fortunet-Fouin; Dominique Arsène 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

Following cimetidine administration, 60% of the dose is excreted as unchanged drug in the urine, and 40% is eliminated by metabolism. We evaluated the effect of liver disease on cimetidine disposition by comparing its kinetics in 7 healthy subjects and 8 patients with alcoholic cirrhosis. Cirrhotic

Severity of disease and quality of life:
Severity of disease and quality of life: A comparison in patients with cancer and benign disease
✍ J. O. Hörnquist; B. Hansson; I. Åkerlind; J. Larsson 📂 Article 📅 1992 🏛 Springer Netherlands 🌐 English ⚖ 691 KB

The aim of our study was to compare the quality of life in patients with malignant and benign diseases. Eighty-nine females and 110 males (mean age 59 years) from the surgical unit at the University Hospital of Linköping were examined. Ninety-five subjects suffering from a gastrointestinal malignanc

In vivo assessment of liver cell apoptos
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
✍ Anna Wieckowska; Nizar N. Zein; Lisa M. Yerian; A. Rocio Lopez; Arthur J. McCull 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

In patients with nonalcoholic fatty liver disease (NAFLD), a liver biopsy remains the only reliable way to differentiate simple steatosis from nonalcoholic steatohepatitis (NASH). Noninvasive methods are urgently needed. Increasing evidence suggests hepatocyte apoptosis is a key mediator of liver in